Charleston Neuroscience — Ladson, South Carolina

Charleston Neuroscience is a clinical research site located in Ladson, South Carolina, United States 29456.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Charleston Neuroscience has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Diabetic Macular Edema, Diabetic Retinopathy.

Sponsors: Hoffmann-La Roche.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Ladson

Browse all research sites in South Carolina · View every site in Ladson

• Charleston Neuroscience Institute
• Carolina Cataract & Laser Center
• Charleston Neuroscience Inst
• Regeneron Study Site
• Charleston Neuroscience Institute - Ladson
• Trident Cardiology
• Adverum Clinical Site 222
• Ladson, SC
• Carolina Cataract and Laser Center
• Charleston Neuroscience Institute /ID# 256235
• Opthea Investigational Site

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Charleston Neuroscience?

Charleston Neuroscience has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Charleston Neuroscience conducted?

Charleston Neuroscience has 2 clinical trials on record, with 1 currently active. Their work covers Diabetic Macular Edema, Diabetic Retinopathy.

Is Charleston Neuroscience accredited by Crixeo Clinical Trials?

Charleston Neuroscience has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Charleston Neuroscience?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.